Market News

Breaking headlines and analysis across every asset class.

Markets
MarketBeat • Sep 17, 2026
Targa Resources, Inc. $TRGP Shares Sold by Corient Private Wealth LP

Corient Private Wealth LP reduced its stake in Targa Resources (TRGP) by 15% in Q2, selling 7,510 shares but retaining 42,659 shares valued at $11.4 million. Despite this, institutional investors and hedge funds still own a significant 92.13% of the company. Analysts maintain a bullish outlook on TRGP, with a consensus "Buy" rating and an average price target of $310.88, following strong Q2 earnings where the company beat EPS estimates.

Earnings
MarketBeat • Sep 17, 2026
Squarepoint Ops LLC Sells 229,372 Shares of Atlas Energy Solutions Inc. $AESI

Squarepoint Ops LLC significantly reduced its holdings in Atlas Energy Solutions Inc. by selling 75.1% of its stake, totaling 229,372 shares. Despite this sell-off, other institutional investors have recently increased their positions in the company. Atlas Energy Solutions, which provides proppant and logistics services to oil and natural gas producers, reported a quarterly loss but exceeded revenue expectations.

Earnings
MarketBeat • Sep 17, 2026
Squarepoint Ops LLC Invests $1.36 Million in Weis Markets, Inc. $WMK

Squarepoint Ops LLC has invested approximately $1.36 million in Weis Markets, Inc. by acquiring 17,432 shares, representing about 0.07% of the company. Weis Markets shares were trading at $73.36, up 1.8%, with a market capitalization of $1.82 billion, and the company recently reported quarterly revenue of $1.28 billion and earnings of $0.92 per share. The company also announced a quarterly dividend of $0.34 per share, translating to a 1.9% yield, while MarketBeat maintains a "Buy" rating for the

Markets
Investing.com Canada • Sep 17, 2026
Roth/MKM initiates Abeona Therapeutics stock with buy rating By Investing.com

Roth/MKM has initiated coverage on Abeona Therapeutics (NASDAQ: ABEO) with a Buy rating and a price target of $17.00, citing the undervaluation of the stock and the strong profile of its therapy, ZEVASKYN. The firm projects Abeona Therapeutics to achieve GAAP net income profitability by Q1 2027 and over $275 million in sales by 2029, with significant revenue growth already demonstrated by ZEVASKYN. ZEVASKYN, priced at $3.1 million, targets a rare skin disease and has received no payor denials, w

Earnings
MarketBeat • Sep 17, 2026
National Pension Service Raises Stake in International Business Machines Corporation $IBM

National Pension Service increased its stake in International Business Machines Corporation (IBM) by 2.8% during the second quarter, bringing its total ownership to 2.35 million shares valued at $660.8 million. This comes as IBM's subsidiary, Anderon, secured a $1 billion CHIPS Act award for a quantum wafer foundry, enhancing IBM's long-term quantum computing strategy. Despite this strategic gain, IBM's recent earnings matched expectations but revenue fell short, leading to some profit-taking an

Earnings
MarketBeat • Sep 17, 2026
Bank of America Corp DE Makes New Investment in Archrock, Inc. $AROC

Bank of America Corp DE has made a significant new investment in Archrock, Inc. (NYSE:AROC), acquiring 6.44 million shares valued at approximately $262.1 million, representing 3.67% of the company. This comes as Archrock reported quarterly results that missed analyst expectations but also announced an increased quarterly dividend. Analysts maintain a "Moderate Buy" consensus for Archrock despite the mixed financial performance.

Earnings
MarketBeat • Sep 17, 2026
Squarepoint Ops LLC Invests $1.26 Million in Astronics Corporation $ATRO

Squarepoint Ops LLC has acquired 15,555 shares of Astronics Corporation (NASDAQ:ATRO) for approximately $1.26 million during the second quarter. Institutional ownership of Astronics stands at 56.68%, with other funds also increasing their positions. The company reported strong Q2 earnings with an EPS of $0.70 and revenue up 46.9% year-over-year, and analysts have a "Moderate Buy" consensus rating with a $74.17 average price target.

Earnings
MarketBeat • Sep 17, 2026
AMERISAFE, Inc. (NASDAQ:AMSF) Receives Consensus Recommendation of "Hold" from Analysts

AMERISAFE, Inc. (NASDAQ:AMSF) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $44.00, despite recent downgrades. The company's shares opened near a one-year low at $24.71, with a market capitalization of approximately $458 million. AMERISAFE recently reported Q2 earnings of $0.44 per share, missing estimates, while revenue exceeded expectations, and announced a quarterly dividend of $0.41 per share, equating to a 6.6% annualized yield.

Earnings
MarketBeat • Sep 17, 2026
Tidal Investments LLC Boosts Stock Position in Affiliated Managers Group, Inc. $AMG

Tidal Investments LLC significantly increased its stake in Affiliated Managers Group (NYSE:AMG) by 129.8% in the second quarter, now holding 6,355 shares valued at $2.15 million. Other institutional investors also raised their holdings, with collective institutional ownership reaching 95.3%. Analysts maintain a positive "Buy" rating for AMG, with an average price target of $370.86, and the company recently surpassed quarterly earnings and revenue expectations.

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.